STVN
Stevanato Group SpA
NYSE · Healthcare · Medical - Instruments & Supplies · IT
$21.70
−4.28%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $0.18
- Revenue estimate
- $369.1M
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- $0.16
- EPS estimate
- $0.14
- Revenue actual
- $344.9M
- Revenue estimate
- $340.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +9.5%
- Revenue beats (12Q)
- 6
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | $0.14 | $0.16 | Beat 10.50% | $344.9M |
| May 7, 2026 | $0.12 | $0.13 | Beat 8.33% | $316.1M |
| Mar 4, 2026 | $0.20 | $0.21 | Beat 5.00% | $403.2M |
| Nov 6, 2025 | $0.14 | $0.16 | Beat 14.29% | $355.1M |
| May 8, 2025 | $0.10 | $0.11 | Beat 10.00% | $281.3M |
| Mar 6, 2025 | $0.20 | $0.20 | In line | $342.3M |
| May 9, 2024 | $0.12 | $0.09 | Miss -27.28% | $253.5M |
| Mar 7, 2024 | $0.21 | $0.20 | Miss -5.25% | $352.6M |
| Oct 31, 2023 | $0.16 | $0.16 | In line | $286.3M |
| Jul 28, 2023 | $0.14 | $0.15 | Beat 7.68% | $278.5M |
| May 4, 2023 | $0.13 | $0.12 | Miss -8.32% | $258.7M |
| Mar 2, 2023 | $0.17 | $0.19 | Beat 12.52% | $314.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026